[go: up one dir, main page]

BR9709060A - Composto processo para a preparação do mesmo composição farmacéutica uso de um composto e método para reduzir ou prevenir perda óssea - Google Patents

Composto processo para a preparação do mesmo composição farmacéutica uso de um composto e método para reduzir ou prevenir perda óssea

Info

Publication number
BR9709060A
BR9709060A BR9709060A BR9709060A BR9709060A BR 9709060 A BR9709060 A BR 9709060A BR 9709060 A BR9709060 A BR 9709060A BR 9709060 A BR9709060 A BR 9709060A BR 9709060 A BR9709060 A BR 9709060A
Authority
BR
Brazil
Prior art keywords
compound
bone loss
preparation
reduce
pharmaceutical composition
Prior art date
Application number
BR9709060A
Other languages
English (en)
Inventor
Svend Treppendahl
Klaus Snej Jensen
Scott E Mcgraw
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9709060A publication Critical patent/BR9709060A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR9709060A 1996-05-08 1997-05-07 Composto processo para a preparação do mesmo composição farmacéutica uso de um composto e método para reduzir ou prevenir perda óssea BR9709060A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK55296 1996-05-08
PCT/DK1997/000211 WO1997042184A1 (en) 1996-05-08 1997-05-07 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen fumarate

Publications (1)

Publication Number Publication Date
BR9709060A true BR9709060A (pt) 1999-08-03

Family

ID=8094838

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709060A BR9709060A (pt) 1996-05-08 1997-05-07 Composto processo para a preparação do mesmo composição farmacéutica uso de um composto e método para reduzir ou prevenir perda óssea

Country Status (17)

Country Link
EP (1) EP0912543B1 (pt)
JP (1) JP2951410B2 (pt)
KR (1) KR20000010644A (pt)
CN (1) CN1218462A (pt)
AT (1) ATE262516T1 (pt)
AU (1) AU710334B2 (pt)
BR (1) BR9709060A (pt)
CA (1) CA2253284A1 (pt)
CZ (1) CZ359898A3 (pt)
DE (1) DE69728271D1 (pt)
HU (1) HUP9901738A3 (pt)
IL (1) IL126345A (pt)
NO (1) NO985205L (pt)
PL (1) PL329624A1 (pt)
RU (1) RU2182149C2 (pt)
WO (1) WO1997042184A1 (pt)
ZA (1) ZA973961B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104166678B (zh) * 2014-07-09 2018-04-10 苏州市职业大学 一种面向汉语微博的多种潜在属性整体挖掘系统及方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
JPH11501953A (ja) 1999-02-16
WO1997042184A1 (en) 1997-11-13
CN1218462A (zh) 1999-06-02
EP0912543A1 (en) 1999-05-06
CA2253284A1 (en) 1997-11-13
EP0912543B1 (en) 2004-03-24
HUP9901738A2 (en) 2000-07-28
RU2182149C2 (ru) 2002-05-10
DE69728271D1 (en) 2004-04-29
CZ359898A3 (cs) 1999-05-12
ATE262516T1 (de) 2004-04-15
PL329624A1 (en) 1999-03-29
KR20000010644A (ko) 2000-02-25
HUP9901738A3 (en) 2000-12-28
AU2763897A (en) 1997-11-26
NO985205D0 (no) 1998-11-06
AU710334B2 (en) 1999-09-16
IL126345A (en) 2001-07-24
NO985205L (no) 1998-11-06
JP2951410B2 (ja) 1999-09-20
ZA973961B (en) 1997-12-04
IL126345A0 (en) 1999-05-09

Similar Documents

Publication Publication Date Title
BR9407239A (pt) Azadioxacicloalquenos substituídos
AU3366297A (en) Polymorphic compounds
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
BR9711135A (pt) Composto composi-Æo farmac-utica utiliza-Æo de um composto e processos para prepara-Æo de um composto e para inibi-Æo de Äxido-equaleno ciclase num animal de sangue quente requerendo um tal tratamento
LV12811B (lv) Jauni (r)-5-karbamoil-8-fluor-3-n,n-divaizvietoti-amino-3,4-dihidro-2h-1-benzopirāni
BR9406362A (pt) Composto,processo para a preparação do mesmo e composição anti-nuclear
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
AU3631197A (en) N-benzylpiperidine and tetrahydropyridine derivatives
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
CA2047744A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
AU5652796A (en) Solid compositions containing polyethyleneoxide and a non-am orphous active principle
PT865498E (pt) Processo para a preparacao de ciclodepsipeptideos com 24 atomos no anel substituidos contendo acido aril-lactico
DK0891341T3 (da) 1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider
AU2003271811A1 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
BR9914811A (pt) Processo para a preparação de derivados de quercetina e isoquercetina
BR9709060A (pt) Composto processo para a preparação do mesmo composição farmacéutica uso de um composto e método para reduzir ou prevenir perda óssea
ZA200005110B (en) Process for preparing intermediates.
GR3029590T3 (en) Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
HUT53103A (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
IL116646A (en) Antifungal fusacandins, process for their preparation, pharmaceutical compositions containing them and uses thereof
AU5588598A (en) Heregulin antagonists and methods for their use
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
ES2166007T3 (es) Procedimiento para la preparacion de antraquinonas sustituidas.
BR9910370A (pt) Compostos de cefalosporina, processo para preparar compostos de cefalosporina, e, composições antimicrobianas
BR0109252A (pt) Composto, processo para produzir um composto, composição farmacêutica, e, uso de um composto ou de uma composição

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements